Everest Group

OCTOBER 24, 2024

By engaging a third party for this process, companies ensure an objective and independent assessment, avoiding potential biases or limitations in internal evaluations. The reason was a provider-biased cost of living (COLA) clause.

Third Party Contracting 130

Third Party Contracting Outsourcing Right-Sizing Cost Control 130

SirionLabs

JUNE 13, 2022

Trial outcomes are what ultimately dictate if a product will receive the necessary regulatory approval on time to go to market. It also offers the necessary data-led evidence a pharma business will need to justify the cost of R&D to shareholders, improve market position, and continue investing in further drug development.

Pharmaceuticals 52

Pharmaceuticals Third Party Contracting Outsourcing Research 52

SirionLabs

JUNE 13, 2022

Trial outcomes are what ultimately dictate if a product will receive the necessary regulatory approval on time to go to market. It also offers the necessary data-led evidence a pharma business will need to justify the cost of R&D to shareholders, improve market position, and continue investing in further drug development.

Pharmaceuticals 52

Pharmaceuticals Third Party Contracting Outsourcing Research 52

SirionLabs

MAY 9, 2022

Only a few hours after the news came out, they decided to revisit merger guidelines to prevent any unfair practices that could affect competition in the market. As a result, companies often find themselves grappling with a labor-intensive manual review process that requires significant time to identify key risk elements in contracts.

Third Party Contracting 40

Third Party Contracting Right-Sizing Regulations Collaborations 40